Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.
About
PhosPrint develops laser bioprinting systems for regenerative medicine and biosensor applications, enabling highly precise and rapid delivery of cells and bio-inks onto targeted tissues. Their lead program focuses on in-vivo printing for urinary bladder repair, having completed preclinical studies and advancing into clinical trials. The company's core product is the PhosDB I, a high-resolution laser bioprinter.
Tags
Total Employees
10
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does PhosPrint do?
PhosPrint develops laser bioprinting systems for regenerative medicine and biosensor applications, enabling highly precise and rapid delivery of cells and bio-inks onto targeted tissues. Their lead program focuses on in-vivo printing for urinary bladder repair, having completed preclinical studies and advancing into clinical trials. The company's core product is the PhosDB I, a high-resolution laser bioprinter.
How much funding has PhosPrint raised?
PhosPrint has raised a total of $2M in funding. The most recent round on record is Seed.
Where is PhosPrint headquartered?
PhosPrint is headquartered in Greece.
When was PhosPrint founded?
PhosPrint was founded in 2018.
What industry does PhosPrint operate in?
PhosPrint operates in Biotech, MedTech, HealthTech, 3D Printing, Advanced Manufacturing, Tissue Engineering.
How many employees does PhosPrint have?
PhosPrint has approximately 10 people on record.